Fortis Healthcare sets board meeting date to declare Q3 results 2026. Details here

The board of directors of Fortis Healthcare Limited is scheduled to meet on Friday, February 13, 2026 to consider and approve Q3 results, as per the company's announcement in an exchange filing.

“….the Board of Directors of the Company will be held on Friday, February 13, 2026, to inter-alia, consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and period ended December 31, 2025,” said the company in an exchange filing.

Fortis Healthcare reported an 86% year-on-year surge in consolidated net profit, amounting to ₹328 crore for the quarter ending in September. In the same quarter of the previous fiscal year, the healthcare giant had a net profit of ₹176 crore.

Revenue from operations increased to ₹2,331 crore for the quarter, compared to ₹1,988 crore in the corresponding period last year, as stated by Fortis Healthcare in a regulatory filing.

Recent Update

In December, Fortis Healthcare announced that it has finalized an agreement to purchase People Tree Hospital, located in Bengaluru, for ₹430 crore. The company has established definitive agreements to acquire the 125-bedded facility in Yeshwanthpur, Bengaluru, through a complete acquisition of TMI Healthcare Pvt Ltd, the organization that operates the People Tree Hospital business.

This acquisition will be carried out by Fortis' wholly-owned subsidiary, International Hospital Limited (IHL), as stated in their announcement.

The healthcare provider mentioned that an additional investment of ₹410 crore is planned over the next three years to enhance bed capacity, medical equipment, and clinical programs, which will include radiation oncology.

Fortis Healthcare share price today

Fortis Healthcare share price today opened at ₹850.25 apiece on the BSE, the stock touched an intraday high of ₹858.40 apiece and an intraday low of ₹844.55.

At 14:28 IST, Fortis Healthcare share price was trading 0.64%) lower at ₹851.85 apiece on the BSE.

According to Ruchit Jain, VP - Head of Equity Technical Research, Motilal Oswal Financial Services, the stock has been consolidating within a narrow range near its 200 DEMA. The immediate support is placed around Rs.800 while resistance is seen around Rs. 900. A trended move is expected only on a breakout beyond this range.

Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decision.